Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silibinin for amatoxin poisoning
NCT00915681Phase 2Terminated
- Sponsor
- Viatris
- Start
- Nov 2009
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silibinin in amatoxin poisoning, sponsored by Viatris. Started Nov 2009; status: terminated.
02
Drugs
silibinin
03
Conditions
amatoxin poisoning
Beyond the preview
Go deeper on NCT00915681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915681.